baber/WOPTO huggingface dataset:
Patent AU-2003267511-A1 (AU)
Title: Use of pthrp antagonists for treating renal cell carcinoma
Inventor: MASSFELDER THIERRY
IPC: A61P35/00
Filed: 2003-07-04
Abstract: The present invention concerns the use of a PTHrP antagonist for preparing a pharmaceutical composition for treating renal cell carcinoma (RCC) in a mammal and in particular in a human subject. Advantageously, the invention is of particular interest for inhibiting or reducing tumour growth and/or metastasis formation in kidney cancer and its metastatic developments, in particular in the lung and the liver.
Patent AU-2003270048-A1 (AU)
Title: Frequency selective beam forming
Inventor: GAINEY KENNETH M
IPC: H01Q5/00
Filed: 2003-08-29
Abstract: A directive antenna having plural antenna elements is arranged in a parasitic antenna array. Frequency selective components are connected to an active antenna element. Weighting structures are connected to passive antenna elements positioned substantially equidistant from the active antenna element. The active and passive antenna elements are connected by a space-fed power distribution system to produce independently steerable beams having spectrally separated signals.
Patent AU-2003272716-A1 (AU)
Title: Liquid uncrosslinked michael addition oligomers prepared in the presence of a catalyst having both an epoxy moiety and a quaternary salt
Inventor: DAMMANN LAURENCE G
IPC: C08F222/10
Filed: 2003-09-26
Abstract: The uncrosslinked liquid oligomeric compositions of this invention are made by the Michael addition reaction of acetoacetate-functional donor compounds with multifunctional acrylate acceptor compounds where the equivalent ratios of multifunctional acrylate to acetoacetate vary from >=1:1 to >=13.2:1 depending on the functionality of both multifunctional acrylate and acetoacetate in the presence of a catalyst comprising an epoxy moiety and a quaternary salt. Unusable gelled or cured oligomer products occur below the claimed ranges. The liquid oligomers of this invention are further crosslinked to make coatings, laminates and adhesives.
Patent AU-2003294988-A1 (AU)
Title: Fluid spinning system
Inventor: LLANGUERAS ALBERT GALAN I
IPC: D01H4/38
Filed: 2003-12-23
Abstract: The invention relates to a system for spinning in a fluid medium, whereby fibres are transformed into yarns. According to the invention, fibres are introduced into said medium, moved about and transformed into yarn (spinning) by controlling and varying determined parameters of the fluid system and controlling the movement of the fibres to be spun. Moreover, in said fluid medium, the yarns can be subjected to a physical and/or chemical treatment of the type used in the textile sector, as the spinning is being performed. <IMAGE>
Patent AU-2003300509-A1 (AU)
Title: Arrays of electrodes coated with molecules and their production
Inventor: WIRTZ RENE
IPC: C12Q1/6837
Filed: 2003-10-09
Abstract: The present invention provides a method of forming coatings of at least two different coating molecules on at least two electrodes, the method comprising: (a) providing an array of at least two individually-addressable electrodes, (b) allowing a layer of a masking molecule to adsorb onto all electrodes, (c) inducing electrochemical desorption of the masking molecule from at least one but not all electrodes to expose a first set of exposed electrodes, (d) allowing a first coating molecule to adsorb onto the first set of exposed electrodes, (e) exposing all electrodes to a masking molecule to allow adsorption of the masking molecule onto all electrodes, (f) inducing electrochemical desorption of masking molecule from a second set of electrodes to expose a second set of exposed electrodes, (g) allowing a second coating molecule to adsorb onto the second set of exposed electrodes.
Patent WO-2004079251-A1 (WO)
Title: Appareil de reparation d'un raccord de conduit
Inventor: WEAVER RONALD JOHN
IPC: F16L55/26
Filed: 2004-03-03
Abstract: L'invention concerne un appareil d'installation d'une gaine de conduit (10) permettant d'installer une gaine flexible (60) dans une zone de raccord interne entre un conduit principal (12) et un conduit de dérivation cible (13). Cet appareil (10) permettant de réparer les conduits d'égout souterrains peut se déployer à partir du conduit principal (12). Cet appareil (10) comprend : un corps allongé (14) ; un bras latéral flexible (15) présentant une extrémité proximale et distale, l'extrémité proximale du bras étant reliée au corps (14) ; des moyens de guidage (17) reliés à l'extrémité distale du bras, les moyens de guidage (17) possédant une extrémité proximale reliée à l'extrémité distale du bras latéral (15) et une extrémité libre ; et un manchon gonflable (18) qui s'étend au moins en partie sur le corps et le bras (15). Lors de l'utilisation, l'extrémité libre des moyens de guidage (17), ou « lanceurs » fournissent une ligne de raccordement à l'extrémité distale du bras latéral (15) jusque dans le conduit de dérivation cible (13) seulement sous l'effet d'une action externe de poussée ou de tirage du corps (14) dans le sens longitudinal par rapport au conduit principal (12).
Patent WO-2004090136-A1 (WO)
Inventor: SPANGENBERG GERMAN
IPC: C12N15/29
Filed: 2004-04-14
Abstract: The present invention relates to nucleic acid fragments encoding amino acid sequences for flavonoid biosynthetic enzymes in plants, and the use thereof for the modification of, for example, flavonoid biosynthesis in plants, and more specifically the modification of the content of condensed tannins. In particularly preferred embodiments, the invention relates to the combinatorial expression of chalcone synthase (CHS) and/or dihydroflavonol 4-reductase (BAN) and/or leucoanthocyanidine reductase (LAR) in plants to modify, for example, flavonoid biosynthesis or more specifically the content of condensed tannins.
Patent WO-2005027767-A1 (WO)
Inventor: DILLON JAGMOHANBIR SINGH
IPC: A61B19/00
Filed: 2004-09-17
Abstract: L'invention concerne une trousse médicale (50) comprenant un corps de type plateau (52), un couvercle ou une fermeture (54) scellé(e) sur ce corps et/ou une étiquette (56) appliquée fixement sur l'extérieur de la fermeture (54). Une languette autocollante détachable (58) est collée sur l'avant de l'étiquette (56) de sorte à pouvoir être enlevée manuellement et appliquée sur la fiche du patient avant l'ouverture de la trousse. De préférence, la languette (58) comporte des éléments permettant d'identifier l'acte médical et le numéro de lot du fabricant de sorte que les défauts associés à cette trousse puissent être enregistrés avec précision. Cette languette (58) permet également au personnel médical utilisant la trousse d'y apposer une signature ou des initiales et d'y inscrire la date d'utilisation. Selon une variante, la languette (56) peut être appliquée directement sur l'intérieur ou l'extérieur de la trousse (50) plutôt que sur une étiquette séparée. Selon une autre variante, la languette (58) et/ou l'étiquette (56) peut être incluse dans la trousse (50) de sorte que la languette (58) ne puisse pas être enlevée si la trousse n'est pas ouverte et de sorte qu'il n'y ait aucun risque de perdre la languette avant l'ouverture de la trousse.
Patent AU-2004201769-A1 (AU)
Title: Compositions and methods for the treatment of tumors
Inventor: GODDARD AUDREY
IPC: C12N15/11
Filed: 2004-04-27
Abstract: The invention concerns compositions and methods for the diagnosis and treatment of neoplastic cell growth and proliferation in mammals, including humans. The invention is based upon the identification of genes that are amplified in the genome of tumor cells. Such gene amplification is expected to be associated with the overexpression of the gene product as compared to normal cells of the same tissue type and contribute to tumorigenesis. Accordingly, the proteins encoded by the amplified genes are believed to be useful targets for the diagnosis and/or treatment (including prevention) of certain cancers, and may act as predictors of the prognosis of tumor treatment. The present invention is directed to novel polypeptides and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention.
Patent AU-2004222822-A1 (AU)
Title: A factor VIII-polypeptide with factor VIII:C-activity
Inventor: MOURIK JAN AART VAN
IPC: C07K14/755
Filed: 2004-10-22
Abstract: Factor VIII polypeptides having FVIII:C activity that contain modifications in the A3 and/or C1 and/or C2 domains of the sequence of the light chain of Factor VIII, characterized by the binding affinity to low density lipoprotein receptor protein, and methods for producing the same.
Patent AU-2004243475-A1 (AU)
Title: Use of S1P
Inventor: MICHAELIS MARTIN
IPC: G01N33/68
Filed: 2004-05-15
Abstract: Using sphingosine-1-phosphate (S1P), its fragments or derivatives in the preparation of pharmaceutical compounds, for the modulation of pain and for identifying compounds that modulate pain, is new. Independent claims are also included for: (1) screening pharmaceuticals useful for modulating or preventing pain involving: either providing a sample containing protein associated with Myc (PAM), its functional fragment or derivative and not containing S1P, providing a second sample containing PAM, its functional fragment or derivative and containing S1P, measuring the PAM activity in both samples, contacting the first sample with a compound, and determining the ability of the compound to mimic S1P function; or providing two samples comprising a cell expressing an S1P receptor, its functional fragment or derivative, contacting one sample with the compound and measuring or comparing the receptor activity in both samples; or providing two samples comprising a cell expressing S1P receptor, its functional fragment or derivative, contacting the samples with S1P, contacting one sample with the compound and measuring the receptor activity or the interaction of S1P and receptor in both samples; or: (a) providing a cell expressing S1P and PAM or their functional fragment or derivative; (b) contacting the cell with a compound; (c) determining the S1P activity in the presence or absence of compound; and (d) comparing the S1P activity; and (2) identification of a compound that modulates pain involving selecting a compound that modulates or mimics the activity of S1P as a test compound, administering the test compound to a subject, and determination of pain modulation in the subject. ACTIVITY : Analgesic; Antiinflammatory. To determine the analgesic effect of sphingosine-1-phosphate (S1P). S1P was delivered to the spinal cord by intrathecal injection. Rats were anesthetized with ketamine (60 mg/kg intraperitoneally) and midazolam (0.5 - 1 mg/kg intraperitoneally). The skin was incised and catheter was fixed with cyanacrylate glue. Three days after surgery rats were placed into a freely moving system, and 10 MicroM S1P (20 Microl) infused through the catheter. Within 15 minutes after stopping the infusion the formalin test was performed. 5% Formaldehyde solution (50 Microl) was injected subcutaneously. Flinches were counted in one minute intervals up to 60 minutes starting right after formalin injection. Flinches of 5 minutes intervals were counted over a period of 60 minutes. A significant decrease in the number of nociceptive responses for phase 2A (20 - 35 minutes after formalin injection) and detected as compared to phosphate buffer saline/dimethylsulfoxide-treated animals. The results showed that the exogenous S1P acts as an analgesic. No specific results are given. MECHANISM OF ACTION : Adenylyl cyclase (AC) (preferably type I, V or Vf) activity inhibitor; Sphingosine-1-phosphate (S1P) receptor binder.
Patent AU-2004248909-A1 (AU)
Title: New pharmaceutical uses of staurosporine derivatives
Inventor: COUTRE STEVEN
IPC: A61P37/08
Filed: 2004-06-17
Abstract: This application relates to the use of staurosporines derivatives for the curative, palliative or prophylactic treatment of allergic rhinitis, allergic dermatitis, drug allergy or food allergy, angioedema, urticaria, sudden infant death syndrome, bronchopulmonary aspergillosis, multiple sclerosis, or mastocytosis; and to a method of treatment of warm-blooded animals in which a therapeutically effective dose of a compound of a Staurosporine Derivative is administered to a warm-blooded animal suffering from one of the diseases or conditions mentioned above.
Patent AU-2004251014-A1 (AU)
Title: Inhalable formulations for treating pulmonary hypertension and methods of using same
Inventor: CHAUDRY IMTIAZ
IPC: A61K31/137
Filed: 2004-06-18
Abstract: The present invention is directed to an inhalable formulation for the treatment of pulmonary hypertension in a mammal (e.g., humans), wherein the formulation comprises at least one hypertension reducing agent, including but not limited to an angiotensin converting enzyme inhibitor, angiotensin receptor blocker, beta-blocker, calcium-channel blocker or vasodilator, or any combination thereof. The formulations of the present invention may be a solution or suspension, and preferably are suitable for administration via nebulization. The present invention is also directed to a method and kit for treating a mammal suffering from pulmonary hypertension.
Patent AU-2004273592-A1 (AU)
Title: Method and device for visually assisting the electrophysiological use of a catheter in the heart
Inventor: HAYAM GAL
IPC: A61B5/055
Filed: 2004-08-24
Abstract: The invention relates to a device and to a method for visual assistance during the electrophysiological use of a catheter in the heart, enabling electroanatomic 3D mapping data relating to an area of the heart to be treated to be visualized during the use of the catheter. Before the catheter is used, 3D image data of a body region containing the area to be treated is detected by means of a method for tomographic 3D imaging. The area to be treated or significant parts thereof are extracted from said 3D image data, in order to obtain selected 3D image data. The electroanatomic 3D mapping data and the selected 3D image data obtained are then classed in terms of position and dimension, and are adjacently visualized, for example, during the catheter ablation. The inventive method and associated device enable the orientation of the operator to be improved during the use of a catheter in the heart.
Patent AU-2004286543-A1 (AU)
Title: Associative memory with entry groups and skip operations
Inventor: THORNBURG DAVID MICHAEL
IPC: G06F/
Filed: 2004-09-30
Abstract: Disclosed are, inter alia, methods, apparatus, data structures, computer-readable medium, mechanisms, and means for merging indications of matching items of multiple groups and possibly associated with skip conditions to identify winning entries of particular use for implementing access control lists. Indications are received typically from an associative memory bank indicating which locations were matched during a lookup operation. Each of the entries is typically associated with one or more hierarchical groups and a skip or no-skip condition. The matching entries are merged to identify one or more wining entries, these being matching entries not in a group that is skipped. A group is typically skipped if the highest priority matching entry of the particular group is associated with a skip condition. A priority encoder can be used to identify a single highest priority winning entry from the winning entries.
Patent AU-2004317328-A1 (AU)
Title: Moisture-hardening hot-melt adhesives, method for the production and the use thereof
Inventor: FRANZMANN GISELHER
IPC: C08G18/42
Filed: 2004-12-22
Abstract: Moisture-crosslinking hot-melt adhesive (I) for immediate further processing of bonded substrates and containing reaction products of di- and/or poly-functional (poly)-isocyanates with hydroxy-polyesters of polyols and dicarboxylic acids or their condensable derivatives, in which the diacids (II) are linear aliphatic dicarboxylic acids with 13-22 methylene groups. An independent claim is also included for a method for the production of (I) as described above.
Patent WO-2005120886-A1 (WO)
Title: Moyen de verrouillage pour siege de securite
Inventor: MACIEJCZYK WIESLAW
IPC: B60N2/28
Filed: 2005-06-08
Abstract: L'invention porte sur un siège pour bébé de véhicule à moteur comprenant une base (10) placée sur un siège du véhicule et s'y fixant, le siège pour bébé (12)  proprement dit se montant réversiblement sur la base (10), et des crochets reliant la base (10) au siège pour bébé dans lequel ils s'engagent lorsque ce dernier, propulsé vers l'avant, tend à se séparer de la base (10).
Patent AU-2005203751-A1 (AU)
Title: Animal litter
Inventor: MATSUO TAKAYUKI
IPC: A01K1/015
Filed: 2005-08-19
Abstract: Provided is a litter, related to litter used for animal litter, which suppresses odors due to excretory substances remaining in litter and litter container using thereof.  This animal litter comprises a plurality of granular materials, one part of a surface thereof comprising first granular material having water-shedding properties and second granular material having liquid-absorbing properties.
Patent AU-2005238078-A1 (AU)
Title: Devices, systems and methods for emergency descent from a height
Inventor: FISCHER ANDREW
IPC: A62B35/04
Filed: 2005-04-27
Abstract: An integral rescue device preferably worn by a firefighter that includes a shock absorbing descender attached to the rescue device, a support line passing through the shock absorbing descender, an anchor connection attached to a first end of the support line in the vicinity of the shock absorbing descender, and an assembly for holding the support line. The assembly preferably includes a plurality of holders in which intermediate loops of the support line are retained near the terminus of each of the intermediate loops. In a preferred embodiment, the shock absorbing descender is attached to a waist belt of a self-contained breathing apparatus carrier with a support line passing through the shock absorbing descender, an anchor connection attached to a first end of the support line in the vicinity of the shock absorbing descender, and an assembly for holding the support line.
Patent AU-2005253691-A1 (AU)
Title: Simultaneous discrete-time analysis of features of substances
Inventor: LAND RAUL
IPC: A61B5/053
Filed: 2005-06-20
Abstract: Method for simultaneous discrete-time analysis of features of systems and substances comprises the steps of generating a set of signals with predetermined frequencies and applying said signals simultaneously to an object and receiving a multiple frequency response and where components with different frequencies are separated by simultaneously sampling the signal with set of sampling pulses wherein the sampling rate is well below the Nyquist rate.
Patent AU-2005259080-A1 (AU)
Title: Laser radiation desorption device for manipulating a liquid sample in the form of individual drops, thereby making it possible to carry out the chemical and biological treatment thereof
Inventor: LEPESANT JEAN-PIERRE
IPC: B01F13/00
Filed: 2005-06-06
Abstract: The invention relates to an integrated system for microfluidic analysis of a liquid sample comprising a liquid sample preparing means (100) which is provided with a displacement means (101) for introducing the sample and reagents and for transmitting said sample and reagents to a second means (200) for chemically or biochemically treating the liquid sample drops, wherein said treating means comprises also means (201) for displacing sample drops to means (300) for drop analysis. Said invention is particularly suitable for a laser radiation desorption device comprising a system for manipulating the sample and reagents in the form of drops, which is provided with one or several loading posts, one or several transport paths consisting of interdigitated electrodes, one or several chemical or biochemical treatment areas and at least one system for switching to a conductive post on which a laser radiation desorption can be carried out.
Patent AU-2005270918-A1 (AU)
Title: Therapeutic and diagnostic methods and compositions targeting 4Ig-B7-H3 and its counterpart NK cell receptor
Inventor: BOTTINO CHRISTINA
IPC: C07K16/28
Filed: 2005-08-02
Abstract: The present invention relates to the identification of 4Ig-B7-H3 protein as a tumor associated molecule that imparts protection from NK cell-mediated lysis via a 4Ig-B7-H3 receptor on NK cells. The invention provides compounds that interfere with interactions between the 4Ig-B7-H3 protein and its receptor that can be used to potentiate NK cell cytotoxicity. Also provided are compounds that bind 4Ig-B7-H3-expressing cells so as to inhibit or eliminate them. The compounds are particularly useful in the treatment of tumors, inflammatory conditions, infections and transplantation. Also provided are methods for diagnosing disease by detecting a 4Ig-B7-H3 protein.
Patent AU-2005285722-A1 (AU)
Title: Transmitting/receiving point-to-multipoint service in wireless communication system
Inventor: CHUN SUNG DUCK
IPC: H04B7/26
Filed: 2005-08-29
Abstract: A method for controlling a user equipment (UE) capable of receiving a point-to-multipoint service in a wireless communication system comprises receiving the point-to-multipoint service on a physical channel from a network. The method also comprises receiving a first scheduling indicator associated with a number of scheduling periods where there is no transmission related to the point-to-multipoint service, wherein each scheduling period is associated with a scheduling indicator. The method also comprises receiving the point-to-multipoint service through the physical channel after the number of scheduling periods where there is no transmission. The point-to-multipoint service and the first scheduling indicator are received on the same physical channel. The method may further comprise receiving a second scheduling indicator after the number of scheduling periods where there is no transmission. The method may further comprise receiving the point-to-multipoint service through the physical channel in response to the second scheduling indicator.
Patent WO-2007134404-A1 (WO)
Title: Système de clôture
Inventor: ANDREWS LAURENCE SCOTT
IPC: E04H17/14
Filed: 2007-05-24
Abstract: La présente invention décrit une clôture (2) comprenant une pluralité de poteaux (4) maintenus espacés et au moins une glissière (6, 8) s'étendant entre des poteaux voisins. La clôture comporte des moyens de support (10, 16) supportant les glissières et reçus dans un canal (14) des poteaux. Ces moyens de support peuvent comprendre une ferrure (16) destinée à supporter une glissière supérieure (6) et un élément support (10) destiné à supporter une glissière inférieure (8). Chaque élément support (10) est généralement reçu dans un piètement (12) de la clôture qui lui correspond, de sorte que ces poteaux (4) sont maintenus à la verticale.
Patent AU-2007202272-A1 (AU)
Title: Wrinkle free garment and method of manufacture
Inventor: CHEN BAI-SHUN
IPC: A41D/
Filed: 2007-05-21
Abstract: A method of manufacturing wrinkle-free garment seams and garments made therefrom comprises (a) placing a bonding element comprising a thermal adhesive between garment components; (b) stitching along a seam line; and (c) applying heat and/or pressure to cause the adhesive to melt and flow along the seam to bond at least one garment component. The thermal adhesive has a melting point of higher than about 150° C., preferably in the range about 160° C. to about 190° C. Alternatively, a bonding element comprising any adhesive material and having a substantially U shape is used to make various seams, such as a yoke seam, a shoulder seam, a side seam, a pocket seam, a hem button stay seam, a sleeve seam, a collar seam, etc. Wrinkle free garments, such as shirts, pants, blouses, skirts, etc., incorporating the seams are produced.